Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)
CUSIP: 30050B101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Class A Common Stock, par value $0.01 per share
- Shares outstanding
- 112,318,617
- Total 13F shares
- 129,270,440
- Share change
- +229,433
- Total reported value
- $3,653,744,995
- Put/Call ratio
- 121%
- Price per share
- $28.28
- Number of holders
- 255
- Value change
- +$36,997,360
- Number of buys
- 125
- Number of sells
- 127
Quarterly Holders Quick Answers
What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 30050B101:
Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
9.9%
|
11,168,712
|
$213,545,774 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.8%
|
11,055,882
|
$211,388,463 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.7%
|
8,687,010
|
$166,095,630 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
7.6%
|
8,514,862
|
$162,804,161 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
5.5%
|
6,125,832
|
$117,125,913 | — | 30 Jun 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
4.5%
|
5,026,043
|
$96,097,942 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.9%
|
4,354,740
|
$83,262,629 | — | 30 Jun 2024 | |
| Engaged Capital LLC |
13F
|
Company |
3.7%
|
4,111,458
|
$78,611,077 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
3.6%
|
4,077,500
|
$77,961,800 | — | 30 Jun 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
3.3%
|
3,739,119
|
$71,491,955 | — | 30 Jun 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
2.7%
|
3,075,727
|
$58,807,900 | — | 30 Jun 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
2.7%
|
3,031,988
|
$57,971,611 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
2,699,408
|
$51,612,681 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.3%
|
2,605,615
|
$49,819,359 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,601,575
|
$49,752,183 | — | 30 Jun 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
2.3%
|
2,582,077
|
$49,369,303 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.1%
|
2,368,255
|
$45,286,258 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.8%
|
2,048,341
|
$39,164,275 | — | 30 Jun 2024 | |
| Bellevue Group AG |
13F
|
Company |
1.5%
|
1,669,835
|
$31,927,246 | — | 30 Jun 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.4%
|
1,617,452
|
$30,925,682 | — | 30 Jun 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.4%
|
1,609,013
|
$30,764,000 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.4%
|
1,574,599
|
$30,106,334 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
1,532,582
|
$29,302,968 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
1,456,284
|
$27,844,150 | — | 30 Jun 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.3%
|
1,445,305
|
$27,634,232 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.2%
|
1,313,504
|
$25,114,205 | — | 30 Jun 2024 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
1.1%
|
1,287,416
|
$24,615,399 | — | 30 Jun 2024 | |
| Frank J. Williams |
3/4/5
|
Director |
—
mixed-class rows
|
903,126
mixed-class rows
|
$24,140,121 | — | 01 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,261,338
|
$24,116,783 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
1,205,053
|
$23,040,613 | — | 30 Jun 2024 | |
| Man Group plc |
13F
|
Company |
1.1%
|
1,200,309
|
$22,949,908 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,190,245
|
$22,757,484 | — | 30 Jun 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.9%
|
1,012,632
|
$19,362,000 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.85%
|
958,137
|
$18,319,579 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.75%
|
843,518
|
$16,128,064 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.7%
|
791,609
|
$15,135,565 | — | 30 Jun 2024 | |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC |
13F
|
Company |
0.69%
|
773,382
|
$14,787,064 | — | 30 Jun 2024 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.65%
|
732,000
|
$13,995,840 | — | 30 Jun 2024 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.65%
|
727,658
|
$13,912,821 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.64%
|
722,959
|
$13,824,000 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.58%
|
645,961
|
$12,350,774 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.57%
|
638,164
|
$12,201,695 | — | 30 Jun 2024 | |
| Camber Capital Management LP |
13F
|
Company |
0.56%
|
625,000
|
$11,950,000 | — | 30 Jun 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.58%
|
645,846
|
$11,890,024 | — | 30 Jun 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.54%
|
611,816
|
$11,697,923 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
610,422
|
$11,671,269 | — | 30 Jun 2024 | |
| Summit Creek Advisors LLC |
13F
|
Company |
0.48%
|
543,241
|
$10,386,768 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.46%
|
515,090
|
$9,848,521 | — | 30 Jun 2024 | |
| Hodges Capital Management Inc. |
13F
|
Company |
0.45%
|
505,635
|
$9,667,741 | — | 30 Jun 2024 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.45%
|
503,935
|
$9,635,236 | — | 30 Jun 2024 |
Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q3 2024
As of 30 Sep 2024,
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by
255 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,270,440 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, FMR LLC, JPMORGAN CHASE & CO, Engaged Capital LLC, EVENTIDE ASSET MANAGEMENT, LLC, and Granahan Investment Management, LLC.
This page lists
256
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
239
Q3 2024 holders
255
Holder diff
16
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.